546 related articles for article (PubMed ID: 8242866)
21. Squamous cell hyperplastic foci: precursors of cutaneous papillomas induced in SENCAR mice by a two-stage carcinogenesis regimen.
Binder RL; Johnson GR; Gallagher PM; Stockman SL; Sundberg JP; Conti CJ
Cancer Res; 1998 Oct; 58(19):4314-23. PubMed ID: 9766659
[TBL] [Abstract][Full Text] [Related]
22. Hyperthermia and phorbol ester tumor promotion in mouse skin.
Mitchel RE; Morrison DP; Gragtmans NJ; Jevcak JJ
Carcinogenesis; 1986 Sep; 7(9):1505-10. PubMed ID: 3091284
[TBL] [Abstract][Full Text] [Related]
23. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice.
Slaga TJ
Environ Health Perspect; 1986 Sep; 68():27-32. PubMed ID: 3096709
[TBL] [Abstract][Full Text] [Related]
24. Induction of papillomas with a high probability of conversion to malignancy.
Hennings H; Shores R; Mitchell P; Spangler EF; Yuspa SH
Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of dietary beta-carotene on papilloma and carcinoma formation induced by an initiation-promotion protocol in SENCAR mouse skin.
Chen LC; Sly L; Jones CS; Tarone R; De Luca LM
Carcinogenesis; 1993 Apr; 14(4):713-7. PubMed ID: 8472337
[TBL] [Abstract][Full Text] [Related]
26. Oral mucosal carcinogenesis in SENCAR mice.
Kim TW; Chen Q; Shen X; Regezi JA; Ramos DM; Tanaka H; Jordan RC; Kramer RH
Anticancer Res; 2002; 22(5):2733-40. PubMed ID: 12529989
[TBL] [Abstract][Full Text] [Related]
27. Acceleration of papilloma growth in mice fed high-fat diets during promotion of two-stage skin carcinogenesis.
Birt DF; Pelling JC; Tibbels MG; Schweickert L
Nutr Cancer; 1989; 12(2):161-8. PubMed ID: 2496398
[TBL] [Abstract][Full Text] [Related]
28. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
30. Effects of short-term exposure to the tumor promoter, 12-O-tetradecanoylphorbol-13-acetate on skin carcinogenesis in SENCAR mice.
Diwan BA; Ward JM; Henneman J; Wenk ML
Cancer Lett; 1985 Mar; 26(2):177-84. PubMed ID: 3919937
[TBL] [Abstract][Full Text] [Related]
31. Evidence that mirex promotes a unique population of epidermal cells that cannot be distinguished by their mutant Ha-ras genotype.
Kim TW; Porter KL; Foley JF; Maronpot RR; Smart RC
Mol Carcinog; 1997 Sep; 20(1):115-24. PubMed ID: 9328442
[TBL] [Abstract][Full Text] [Related]
32. Characterization of skin tumor promotion and progression by chrysarobin in SENCAR mice.
Kruszewski FH; Conti CJ; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3783-90. PubMed ID: 3109733
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of Diethylphthalate (CAS No. 84-66-2) in F344/N Rats and B6C3F1 Mice (Dermal Studies) with Dermal Initiation/ Promotion Study of Diethylphthalate and Dimethylphthalate (CAS No. 131-11-3) in Male Swiss (CD-1(R)) Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1995 May; 429():1-286. PubMed ID: 12616302
[TBL] [Abstract][Full Text] [Related]
35. High dietary retinoic acid prevents malignant conversion of skin papillomas induced by a two-stage carcinogenesis protocol in female SENCAR mice.
Chen LC; Sly L; De Luca LM
Carcinogenesis; 1994 Oct; 15(10):2383-6. PubMed ID: 7955082
[TBL] [Abstract][Full Text] [Related]
36. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
37. NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Feb; 441():1-201. PubMed ID: 12595922
[TBL] [Abstract][Full Text] [Related]
38. Malignant conversion of UV radiation and chemically induced mouse skin benign tumors by free-radical-generating compounds.
Athar M; Lloyd JR; Bickers DR; Mukhtar H
Carcinogenesis; 1989 Oct; 10(10):1841-5. PubMed ID: 2507187
[TBL] [Abstract][Full Text] [Related]
39. Lack of promotion of 7,12-dimethylbenz[a]anthracene-initiated mouse skin carcinogenesis by 1.5 GHz electromagnetic near fields.
Imaida K; Kuzutani K; Wang J; Fujiwara O; Ogiso T; Kato K; Shirai T
Carcinogenesis; 2001 Nov; 22(11):1837-41. PubMed ID: 11698347
[TBL] [Abstract][Full Text] [Related]
40. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis.
Miller DR; Viaje A; Rotstein J; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1989 Jan; 49(2):410-4. PubMed ID: 2491955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
